Latest News about Biotech
Recent news which mentions Biotech
From Benzinga
FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease, A Post-Transplant Complication
August 15, 2024
From Benzinga
FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal
August 15, 2024
From Benzinga
In NIH-Cosponsored Monkeypox Virus Study In Congo, SIGA Technologies' Antiviral Tecovirimat Did Not Improve Lesion Resolution, Stock Tanks
August 15, 2024
From Benzinga
From PRLog
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
August 14, 2024
From Benzinga
From Benzinga
Don't Promote Copycat Weight-Loss Drugs Amid Improved Supply, Eli Lilly Asks Doctors, FDA Evaluates
August 14, 2024
From Benzinga
Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability'
August 14, 2024
From Benzinga
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
August 14, 2024
From Benzinga
Acelyrin Cuts Workforce, Deprioritizes Former Lead Drug Izokibep
August 14, 2024
From Benzinga
From Benzinga
From Benzinga
Tony Stark's Choice Vape? Synergy Innovation's Strategic Move To Restore Brands' Identity, Lead Market Niche
August 14, 2024
From Benzinga
Eli Lilly Smashed Estimates Thanks To Unbelievable Demand For Its Diabetes And Weight Loss Blockbusters
August 14, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.